Distribution, Persistence, and Efficacy of Adoptively Transferred Central and Effector Memory-derived Autologous Simian Immunodeficiency Virus-specific CD8+ T Cell Clones in Rhesus Macaques During Acute Infection
Overview
Authors
Affiliations
Plasma viremia decreases coincident with the appearance of virus-specific CD8(+) T cells during acute HIV or SIV infection. This finding, along with demonstrations of viral mutational escape from CD8(+) T cell responses and transient increase in plasma viremia after depletion of CD8(+) T cells in SIV-infected monkeys strongly suggest a role for CD8(+) T cells in controlling HIV/SIV. However, direct quantitative or qualitative correlates between CD8(+) T cell activity and virus control have not been established. To directly assess the impact of large numbers of virus-specific CD8(+) T cells present at time of SIV infection, we transferred in vitro expanded autologous central and effector memory-derived Gag CM9-, Nef YY9-, and Vif WY8-specific CD8(+) T cell clones to acutely infected rhesus macaques. The cells persisted in PBMCs between 4 and 9 d, but were not detected in gut-associated lymphoid tissue or lymph nodes. Interestingly, a high frequency of the infused cells localized to the lungs, where they persisted at high frequency for >6 wk. Although persisting cells in the lungs were Ag reactive, there was no measurable effect on virus load. Sequencing of virus from the animal receiving Nef YY9-specific CD8(+) T cells demonstrated an escape mutation in this epitope <3 wk postinfection, consistent with immune selection pressure by the infused cells. These studies establish methods for adoptive transfer of autologous SIV-specific CD8(+) T cells for evaluating immune control during acute infection and demonstrate that infused cells retain function and persist for at least 2 mo in specific tissues.
Applying a clinical lens to animal models of CAR-T cell therapies.
Duncan B, Dunbar C, Ishii K Mol Ther Methods Clin Dev. 2022; 27:17-31.
PMID: 36156878 PMC: 9478925. DOI: 10.1016/j.omtm.2022.08.008.
Pampusch M, Abdelaal H, Cartwright E, Molden J, Davey B, Sauve J PLoS Pathog. 2022; 18(2):e1009831.
PMID: 35130312 PMC: 8853520. DOI: 10.1371/journal.ppat.1009831.
Miki S, Kawai Y, Nakayama-Hosoya K, Iwabuchi R, Terahara K, Tsunetsugu-Yokota Y J Virol. 2022; 96(6):e0221721.
PMID: 35107374 PMC: 8941871. DOI: 10.1128/jvi.02217-21.
HIV-1-Specific CAR-T Cells With Cell-Intrinsic PD-1 Checkpoint Blockade Enhance Anti-HIV Efficacy .
Jiang Z, Liang H, Pan H, Liang Y, Wang H, Yang X Front Microbiol. 2021; 12:684016.
PMID: 34295319 PMC: 8290485. DOI: 10.3389/fmicb.2021.684016.
McCann C, van Dorp C, Danesh A, Ward A, Dilling T, Mota T J Exp Med. 2021; 218(7).
PMID: 33988715 PMC: 8129803. DOI: 10.1084/jem.20201908.